Skip to content

A single-blind randomized controlled clinical study of electroacupuncture frequency in assisted medical abortion

A single-blind randomized controlled clinical study of electroacupuncture frequency in assisted medical abortion

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056366
Enrollment
Unknown
Registered
2022-02-04
Start date
2022-03-01
Completion date
Unknown
Last updated
2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

medical abortion

Interventions

electroacupuncture 2HZ group:Electroacupuncture was administered at 2HZ
electroacupuncture 50HZ group:Electroacupuncture was administered at 50HZ
electroacupuncture 100HZ group:Electroacupuncture was administered at 100HZ
False acusector group:Sham electroacupuncture treatment

Sponsors

Guangdong Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Women aged between 18 and 40 who plan to undergo medical abortion to terminate pregnancy; 2. The number of days of menopause <= 49d, positive HCG in blood or urine, confirmed as intrauterine pregnancy by B-ultrasound; 3, No contraindications of medical abortion; 4. Patients who have received acupuncture treatment and have never received acupuncture treatment before; 5. Voluntarily participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications of mifepristone and misoprostol, such as adrenal and other endocrine diseases, vascular embolism, cardiovascular diseases, glaucoma, asthma, etc.; 2, Suspected ectopic pregnancy, or pregnancy with an organ, or hyperemesis gravidarum; 3. Long-term use of anti-tuberculosis, anti-epilepsy, anti-depression, anti-prostaglandin drugs, etc. 4. Skin damage, infection or ulcers at the operation site, or pacemaker installation; 5. The fetal sac has been discharged spontaneously before taking misoprostol; 6. Unable to cooperate well with the completion of this study.

Design outcomes

Primary

MeasureTime frame
complete abortion rate;

Secondary

MeasureTime frame
Embryo discharge time;Abdominal pain score;Duration of vaginal bleeding;

Countries

China

Contacts

Public ContactLin Huanmei

Guangdong Hospital of Traditional Chinese Medicine

lhm13760794295@126.com+86 13760794295

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026